Pulse Biosciences (PLSE) Revenue (2021 - 2025)
Pulse Biosciences' quarterly Revenue came in at $86000.0 in Q3 2025, up 1055.56% quarter-over-quarter from -$9000.0 in Q4 2022.
Pulse Biosciences has reported Revenue for 3 years, with the latest figure at $86000.0 in Q3 2025.
- For the quarter ending Q3 2025, Revenue changed N/A year-over-year to $86000.0; the trailing twelve-month figure through Sep 2025 stood at $86000.0 (changed N/A YoY), and the FY2022 full-year result was $700000.0, down 50.63% from the prior year.
- Revenue for Q3 2025 stood at $86000.0, up from -$9000.0 in the prior quarter.
- The five-year high for Revenue was $844000.0 in Q4 2021, with the low at -$9000.0 in Q4 2022.
- Average Revenue over 3 years is $373166.7, with a median of $372000.0 recorded in 2022.
- Peak annual rise in Revenue reached 101.07% in 2022, while the deepest fall reached 101.07% in 2022.
- Tracing PLSE's Revenue over 3 years: stood at $844000.0 in 2021, then slumped by 101.07% to -$9000.0 in 2022, then jumped by 1055.56% to $86000.0 in 2025.
- The last three Revenue figures came in at $86000.0 (Q3 2025), -$9000.0 (Q4 2022), and $300000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 2.77 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 4.71 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 1.43 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 844.90 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 2.01 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 1.02 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.04 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.70 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 982.87 Mn |
| 10 | Pulse Biosciences | 1.72 Bn | 1.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 86,000.00 |
| Dec 31, 2022 | -9,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 444,000.00 |
| Dec 31, 2021 | 844,000.00 |
| Sep 30, 2021 | 574,000.00 |